| || |
According to then FDA, side-effects from Lipitor
(May 23, 2003) FDA announced that Albers Medical Distributors, Inc voluntary recalled 3 lots of 10 mg 90-count bottles of the cholesterol-lowering drug Lipitorâ and is warning healthcare providers and others that these three lots of counterfeit Lipitorâ represent a potentially significant risk to consumers. FDA's investigation into this matter is continuing.
(June 9, 2003) Albers expanded their original voluntary recall to include all lots of Lipitorâ that Albers purchased, which were packaged by Med-Pro.
*Lipitor® (atorvastatin calcium) is a synthetic lipid-lowering agent. Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step in cholesterol biosynthesis.
Disclaimer: The information presented here is not meant to be medical advice nor to act as a substitute for medical advice. Serious side-effects, including death, could result if one were to take any prescription medicine without the supervision of a physician.
Copyright 2003, Thomas Manaugh, PhD